Company / Cash per Share
Sana Biotechnology, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.55
FY2024
5-year range
$0.55 / $9.59
FY2020-FY2024
Trend
-19.5%
vs FY2023
Sector context
#165 of 205
Health Care
What the data says
Sana Biotechnology, Inc.'s cash per share of $0.55 is lower than 80% of companies in the Health Care sector (FY2024). Cash per Share has declined for 4 consecutive years, from $9.59 in FY2020 to $0.55 in FY2024.
Based on SEC 10-K filings.
0.55 in FY2024 with a 3-year CAGR of -28.6%.
Declined from $0.94 to $0.55 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -28.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 205This company $0.55 Sector average $72.93
▼
-99.2% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s cash per share has declined for 4 consecutive years.
- In FY2024, cash per share decreased 19.5% year-over-year.
- Ranks #165 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.55 | -19.5% |
| FY2023 | $0.69 | -26.9% |
| FY2022 | $0.94 | -38.3% |
| FY2021 | $1.52 | -84.1% |
| FY2020 | $9.59 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026